Plain-English translation of NCT06856174 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 4 โ The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This study is testing whether estradiol with or without progesterone โ the same hormone therapy used to treat menopause symptoms in women without HIV โ can safely and effectively help women living with HIV who experience severe hot flashes and night sweats. Researchers want to see if this medication can improve not just these symptoms, but also sleep, mood, bone health, and overall quality of life. About half of participants will receive the active medication, and half will receive a placebo (a look-alike with no active ingredient).
Women living with HIV tend to have worse hot flashes and night sweats during menopause compared to women without HIV, and these symptoms can seriously interfere with sleep, mood, work, and daily life. While this medication is known to work well for menopause symptoms in the general population, doctors don't yet have clear evidence about whether it's safe and effective specifically for women with HIV, or how it might interact with HIV medications.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You would participate in this study for 12 weeks. You'll be randomly assigned to either receive the active hormone medication or a placebo. If you have a uterus, you'll apply a gel to your skin and take a daily pill; if you don't have a uterus, you'll only apply the gel. Throughout the study, you'll keep a daily diary tracking your symptoms and will have visits with the research team to check on how you're doing, have blood work, and answer questions about your mood, sleep, and quality of life.
AI-generated summary from trial data ยท Jun 29, 2026 ยท Not medical advice
United States